# PR #40 Executive Review Brief

Target reading time: **10 minutes**

## 1. Purpose
Validate the exact p.34 conversion candidate as a bounded synthetic/no-PHI pilot and assurance platform.

## 2. Exact Candidate
Start with `artifacts/release/scrimed-p34-release-manifest.json`. Stop if PR #40, commit, tree, candidate, source, validation, review, gate, SBOM, or preview differs.

## 3. What Changed
The wave consolidates release truth, hardens deterministic evidence, focuses Product Console, and productizes six synthetic pilot archetypes without adding clinical authority.

## 4. Highest-Risk Files
Read CRITICAL then HIGH entries in `docs/review/P40_RISK_RANKED_DIFF.md`.

## 5. Governance Model
Rules, evidence, exact-candidate approvals, one-use execution, budgets, and immediate pre-effect revalidation remain fail closed.

## 6. Synthetic-Pilot Boundary
NO_PHI, NONPRODUCTION, no clinical execution, no payer submission, no EHR/device writeback, and no customer-system writes are invariant.

## 7. PHI Controls
PHI egress and storage are blocked; telemetry and evidence retain hashes and redacted operational facts only.

## 8. Approval Controls
Synthetic approvals cannot authorize external execution. Review, merge, deployment, migration, protected-pilot, and production authority remain separate.

## 9. Tenant Isolation
Review tenant-bound approvals, Supabase RLS contracts, cross-tenant negative tests, and hashed tenant evidence.

## 10. Preview Evidence
The accepted target must be the exact Node 24 nonproduction Vercel deployment, with public smoke, desktop/390px checks, protected denial, and no production alias.

## 11. Migrations
Three migrations remain unapplied. Verify checksums and static/disposable evidence; do not authorize production application through this review.

## 12. AAL2
Fresh candidate-bound operator evidence remains required and contains no credential material.

## 13. Supabase
The leaked-password warning remains owner action until the Auth setting is changed and Security Advisor is rerun.

## 14. Security Evidence
Review secret scan, dependency audit, SBOM, adversarial/fuzz/concurrency/failure tests, and fail-closed protected APIs.

## 15. Commercial Authority
Pricing and value outputs are estimated/simulated and nonbinding. Agents cannot sign, discount, promise dates, activate customers, or distribute investor artifacts.

## 16. Reviewer Decision
Record exactly one: **APPROVE_EXACT_HEAD**, **REQUEST_CHANGES**, or **REJECT**. Bind identity and disposition to the exact manifest. Approval grants review evidence only.
